Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000600980 | SCV000726645 | likely benign | not specified | 2018-01-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001184573 | SCV001350594 | likely benign | Hereditary cancer-predisposing syndrome | 2020-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002066545 | SCV002436282 | likely benign | Familial adenomatous polyposis 2 | 2024-10-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001184573 | SCV002532229 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-18 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV001184573 | SCV002696338 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |